Stanford University
Showing 4,321-4,330 of 6,031 Results
-
Alma Rodriguez
Ph.D. Student in Education, admitted Autumn 2024
FLISSC Student Staff, First Generation Low IncomeBioAlma Rodriguez is a first-year Ph.D. student at Stanford’s Graduate School of Education, specializing in Sociology of Education under the supervision of Dr. Anthony Lising Antonio and Dr. Christine Min Wotipka. Alma is a DACA (Deferred Action for Childhood Arrivals) recipient who earned her Bachelor of Arts in Sociology with highest honors from the University of California, Berkeley. Her research interest focuses on the undocumented student population. During her undergrad, Alma completed her senior honor’s thesis under the supervision of the Sociology department at UC Berkeley. Her qualitative research focused on how undocumented students navigate the higher education pipeline. Particularly, Alma is interested in understanding how undocumented students obtain cultural capital and in what ways they implement it in their communities.
Alma’s research focus at Stanford aims to shed light on undocumented Latina student mothers navigating higher education. Specifically, examining how the intersectionality of their identities such as gender, immigration status, and race has constituted a new set of challenges that have shaped their experiences navigating institutions of higher education. -
Carlos Jose Rodriguez Santiago
Ph.D. Student in Chemical Engineering, admitted Autumn 2022
BioCarlos Rodriguez Santiago is a Chemical Engineering PhD candidate working in the lab of Dr. Judith Shizuru to develop protein therapeutics that will facilitate hematopoietic stem cell transplantation without the need for chemotherapy or radiation. His PhD thesis work is at the intersection of immunology, oncology, and protein engineering. Carlos is also a Sarafan CheM-H Lipshultz Graduate Fellow participating in the Chemistry/Biology Interface (CBI) Predoctoral training program which aims to cultivate interactions and thinking across disciplinary lines to enable innovations that improve human health.
Prior to his PhD work, Carlos helped found the Protein Engineering Knowledge Center (PEKC) at Stanfords Innovative Medicines Accelerator (IMA). There he collaborated with researchers to discover and engineer antibodies against therapeutically relevant targets. Several antibodies discovered by Carlos have officially been licensed out for further therapeutic development.
